causal
Basic Science Yields Spillovers Worth Public Investment
Government should invest in basic science where commercial applications are foreseeable but the private market won't act—as with the Human Genome Project, which venture capital rejected in the 1980s as unmonetizable yet later generated roughly 300,000 mostly good-paying jobs once downstream firms could appropriate the basic science—because the rationale is capturing large spillover effects rather than duplicating private financing.
causalpending
Speaker
Simon JohnsonEvidence Quote
“We’re saying, look for those big potential breakthroughs that could have commercial applications and seek solutions that address anything that the private market is not able to do along the way.”
Created: 6/13/2026, 3:27:28 AM
Your notes
Loading notes...